SCHEMBL17489237

SCHEMBL17489237

Cc1nc2c(F)cc(-c3nc(Nc4ccc(NC5CCC(O)CC5)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.61
CDK2 P24941 13/20 0.61
CDK6 Q00534 13/20 0.61
CDK1 P06493 11/20 0.61
CCNB1 P14635 7/20 0.61
CCNE1 P24864 6/20 0.61
CDK9 P50750 5/20 0.61
CCND3 P30281 4/20 0.61
CDK7 P50613 4/20 0.61
CCNA2 P20248 3/20 0.61
KDR P35968 2/20 0.61
CCND1 P24385 2/20 0.61
CIT O14578 1/20 0.61
GAK O14976 1/20 0.61
DYRK3 O43781 1/20 0.61
CCNT1 O60563 1/20 0.61
STK16 O75716 1/20 0.61
CCNK O75909 1/20 0.61
STK10 O94804 1/20 0.61
PRKD3 O94806 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17488646 0.91 CDK4 (0.66) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL17488682 0.89 CDK4 (0.63) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL17489230 0.89 CDK4 (0.73) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL17488701 0.85 CDK4 (0.64) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL25649450 0.84 CDK4 (0.70) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL22003331 0.84 CDK4 (0.62) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL22003337 0.84 CDK4 (0.62) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL22003330 0.84 CDK4 (0.62) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL17477188 0.83 CDK4 (0.63) CDK4CDK2CDK6CDK1CCNB1
SCHEMBL22004016 0.83 CDK4 (0.61) CDK4CDK2CDK6CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016015605-A1 COMPOUNDS AS CDK SMALL-MOLECULE INHIBITORS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-02-04 WO disclosed